This week we put the former principal deputy commissioner of the US Food and Drug Administration, Dr. Josh Sharfstein, on the other side of the mic to answer questions about some of this week's remarkable list of COVID news.
How damaging are conflicting messages from the White House about COVID-19? What happened between the FDA and the White House over COVID-19 vaccine safety? Is Regeneron, a cocktail of monoclonal antibodies, really a "cure"? And why is the New England Journal of Medicine heating up on social media?
Dr. Sharfstein talks with Stephanie Desmon about all this and more.
KEYWORDS: vaccine authorization; health communication; COVID-19 therapy
